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Summary
Glutathione (g-glutamylcysteinyl-glycine, GSH) has
vital functions as thiol redox buffer and cofactor of
antioxidant and detoxiﬁcation enzymes. Plasmodium
falciparum possesses a functional GSH biosynthesis
pathway and contains mM concentrations of the trip-
eptide. It was impossible to delete in P. falciparum the
genesencodingg-glutamylcysteinesynthetase(gGCS)
or glutathione synthetase (GS), the two enzymes
synthesizing GSH, although both gene loci were not
refractory to recombination. Our data show that the
parasites cannot compensate for the loss of GSH bio-
synthesis via GSH uptake. This suggests an important
if not essential function of GSH biosynthesis pathway
fortheparasites.Treatmentwiththeirreversibleinhibi-
tor of gGCS L-buthionine sulfoximine (BSO) reduced
intracellular GSH levels in P. falciparum and was lethal
for their intra-erythrocytic development, corroborat-
ing the suggestion that GSH biosynthesis is important
for parasite survival. Episomal expression of ggcs in
P. falciparum increased tolerance to BSO attributable
to increased levels of gGCS. Concomitantly expres-
sion of glutathione reductase was reduced leading to
an increased GSH efflux. Together these data indicate
that GSH levels are tightly regulated by a functional
GSH biosynthesis and the reduction of GSSG.
Introduction
All living organisms need to maintain an adequate intra-
cellular redox environment. In most organisms glutathione
(g-glutamylcysteinyl-glycine; GSH) represents the major
low molecular weight thiol and its intracellular concentra-
tion varies between 1 and 10 mM with the majority being in
its reduced form. It serves as thiol redox buffer that guar-
antees maintenance of the intracellular reducing environ-
ment (Meister and Anderson, 1983). GSH also acts as
cofactor for enzymes such as glutathione peroxidases,
glutathione-S-transferases (GST) and glyoxylases
(Meister, 1983; Meister andAnderson, 1983; Becker et al.,
2003).All three enzymatic systems are involved in protect-
ing cells against reactive oxygen species, toxic metabolic
intermediates and xenobiotics (Meister and Anderson,
1983; Meister, 1988). In addition, GSH is also known as
non-enzymatic antioxidant either alone or in conjunction
with vitamin C and vitamin E (Linster and Van Schaftingen,
2007,GalliandAzzi,2010).GSHissynthesizeddenovoby
two consecutive ATP-dependent enzymatic reactions
catalysed by g-glutamylcysteine synthetase (gGCS) and
glutathione synthetase (GS) (Meister andAnderson, 1983;
Meister, 1988). Mammalian gGCS is composed of a cata-
lytic and regulatory subunit, which are distinct gene prod-
ucts (Huang et al., 1993a,b). The enzymes from bacteria,
fungiandtheprotozoanparasitesTrypanosomabruceiand
Plasmodiumfalciparumconsistonlyofthecatalyticsubunit
(Coblenz and Wolf, 1995; Lueder and Phillips, 1996; Grif-
ﬁth and Mulcahy, 1999; Lüersen et al., 1999; Kelly et al.,
2002; Baek et al., 2004), suggesting that the way GSH
biosynthesis is regulated differs fundamentally between
mammals and these microorganisms.
The important and versatile functions of GSH suggest
that the tripeptide is vital for most organisms including the
humanmalariaparasiteP. falciparum(Beckeret al.,2003).
P. falciparum is the causative agent of the most severe
formofhumanmalariaandtheinfectionwiththeprotozoan
parasiteleadstoapproximately1millionhumandeathsper
annum. Apart from being a serious public health problem,
malaria is a major economic burden in tropical and sub-
tropical countries, especially in sub-Saharan Africa. The
malariaparasitepossessesahighlydevelopedantioxidant
system to help it cope with the pro-oxidant environment it
encounters during its development in the mammalian and
insect hosts (Müller et al., 2001; Becker et al., 2003; 2004;
Müller, 2004). The GSH system of the parasite consists of
the GSH biosynthesis pathway, glutathione reductase
(GR) to maintain an adequate ratio of reduced GSH to
oxidized glutathione disulphide (GSSG), glyoxalases I and
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© 2011 Blackwell Publishing LtdII, glutaredoxins and a single GST (Farber et al., 1996;
Lüersen et al., 1999; Rahlfs et al., 2001; Harwaldt et al.,
2002; Liebau et al., 2002; Meierjohann et al., 2002a;
Akoachere et al., 2005). GSH also reduces thioredoxin-
disulphides and thus links the two main antioxidant and
redox systems operating in the parasites (Kanzok et al.,
2000; Krnajski et al., 2001; Becker et al., 2003; 2004;
Müller, 2004). In addition, both redox systems provide
reducing equivalents for the reaction catalysed by ribo-
nucleotide reductase and thus are important for DNA syn-
thesis and cell proliferation (Becker et al., 2004; Müller,
2004).
The parasites possess the two enzymes gGCS and GS
to generate the tripeptide de novo from the amino acids
glutamate, cysteine and glycine (Lüersen et al., 1999;
Meierjohann et al., 2002a) and, provided a suitable supply
of the amino acids, are independent of a source of GSH
from their host. Inhibition of the biosynthetic pathway by
the gGCS inhibitor L-buthionine sulfoximine (BSO) is
lethal for P. falciparum during intra-erythrocytic growth,
implying that the parasites rely on a functional GSH bio-
synthesis (Lüersen et al., 2000). Therefore it is surprising
that the related rodent malaria parasite Plasmodium
berghei does not rely on its endogenous GSH biosynthe-
sis during the development in the mammalian host. The
deletion of the P. berghei ggcs gene affects parasite
growth in the red blood cells (RBC) only marginally. The
mutant parasites still contain low but apparently adequate
levels of GSH despite the lack of gGCS function, presum-
ably because they take up the tripeptide from their host by
a yet unidentiﬁed mechanism. The P. berghei ggcs null
mutants depend however on a functional GSH biosynthe-
sis during their sexual development, possibly because the
demand for the tripeptide is increased during these devel-
opmental stages or the insect host does not supply suffi-
cient GSH to complement for a loss of GSH biosynthesis
(Vega-Rodriguez et al., 2009). Similarly, it was recently
shown that gr is not essential in P. berghei during intra-
erythrocytic growth but is crucial for the development of
the insect stages of the parasites (Buchholz et al., 2010;
Pastrana-Mena et al., 2010). Interestingly, double null
mutants for ggcs and gr in P. berghei are non-viable
(Buchholz et al., 2010), indicating that the loss of either of
these genes renders the other indispensable in RBC
stages, presumably because a residual concentration of
GSH needs to be maintained.
Our study provides evidence that, in contrast to the
situation in P. berghei, GSH biosynthesis is vital in the
human malaria parasite P. falciparum for blood stage
development during in vitro growth. The reason for this is
that P. falciparum is not taking up substantial amounts of
GSH from the external environment but loose large
amounts of GSSG through signiﬁcant efflux (Atamna and
Ginsburg, 1997; Ayi et al., 1998; Lüersen et al., 2000).
Probing the role of GSH biosynthesis by using BSO, the
speciﬁc inhibitor of gGCS (Griffith, 1982), and by overex-
pressing gGCS, we further demonstrate that P. falciparum
GSH metabolism is tightly regulated by both GSH biosyn-
thesis and GSSG reduction.
Results
The ggcs and gs genes are not disrupted by single
homologous recombination
Attempts to disrupt the ggcs or gs gene loci were unsuc-
cessful using constructs generated in the pHH1 transfec-
tion plasmid (Reed et al., 2000). The constructs contained
either an 800 bp fragment of the ggcs gene truncated at
the 5′ and 3′ end (pHH1Dggcs) or a 1004 bp fragment of
gs lacking the 5′ and 3′ end of the gs gene (pHH1Dgs).
Both constructs lacked the ATG start codon and pos-
sessed an artiﬁcial stop codon (Fig. 1). It was expected
that upon targeting the respective gene loci, the endog-
enous genes would be disrupted to result in the formation
of pseudo-diploid loci with two truncated copies of the
respective genes (Fig. 1A and C). WR99210 resistant
parasites were observed in Giemsa stained thin smears 4
weeks after transfection. Parasites were taken through
so-called ‘drug selection cycles’, where the selectable
drug was withdrawn for a period of 3 weeks followed by a
short period with addition of drug until the parasitaemia
reached 5% again. Genomic DNA was isolated in each
drug selection cycle and subjected to diagnostic diges-
tions followed by Southern blot analyses. The parasite line
transfected with pHH1Dggcs showed the presence of the
plasmid (2.6 kb) and of the endogenous gene (3.7 kb).
DNA fragments indicating the targeting of the gene locus
were not observed (Fig. 1B). This suggests that the ggcs
gene locus is either not targeted by the transfection
plasmid or that the gene is essential under the in vitro
culture conditions.
Asimilar approach was taken for the disruption of the gs
gene (Fig. 1C and D). The diagnostic Southern blot after
transfection of parasites with pHH1Dgs probed with the gs
speciﬁc probe should detect a 8.5 kb endogenous gs frag-
ment and the expected size of the restricted transfection
plasmid is 1.3 kb with this probe. Upon recombination of
the plasmid, the expected DNA fragments detectable
on the blot should be 1.7 kb and 7.8 kb respectively
(Fig. 1C). The endogenous gs gene was detected in wild-
type and transfected parasite lines and the transfected
parasite line also contained the diagnostic plasmid band
when DNA was isolated after drug selection cycle 4
(Fig. 1D). However, no DNA fragments indicative of a gs
gene disruption were detected suggesting that even after
four drug selection cycles the plasmid had not targeted
the gene locus of interest.
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homologous recombination
We further attempted to replace the ggcs and gs genes
using knockout constructs based on the plasmid pCC4.
This plasmid allows for positive and negative selection
and confers double cross-over recombination (Braks
et al., 2006; Maier et al., 2006) (Fig. 2). To support para-
site growth in the absence of GSH biosynthesis the
medium was supplemented with 1 mM GSH to compen-
sate for the loss of ggcs or gs. This concentration of GSH
was chosen because it had no adverse effects on parasite
growth and it is well above the physiological levels of the
tripeptide in human plasma and serum, which has been
reported to be between 0.3 and 20 mM (Wendel and
Cikryt, 1980; Jeevanandam et al., 2000; Scibior et al.,
2008). Parasites resistant to blasticidin were identiﬁed 4
weeks after transfection. After each drug selection cycle
parasites were subjected to negative selection with
5-ﬂuorocytosine (5-FC) to select against episomal main-
tenance of the transfection plasmid. Genomic DNA of
positive and negative selected parasites was isolated and
analysed by diagnostic Southern blotting (Fig. 2). The
Southern blots of parasites transfected with pCC4-ggcs
revealed that after three selection cycles the endogenous
gene (3.7 kb) and the plasmid (0.7 kb and 7.3 kb) were
Fig. 1. Gene disruption of ggcs and gs.
A. Schematic representation (not to scale) of the endogenous ggcs locus, the pHH1Dggcs plasmid and the recombined ggcs locus following
single cross-over recombination and integration of the plasmid. NdeI and XhoI restriction sites and the sizes of the resulting fragments are
indicated. The plasmid contains a fragment of ggcs truncated at both 5′ and 3′ ends (Dggcs) and a human dihydrofolate reductase selectable
marker cassette (hDHFR). Recombination between plasmid and endogenous locus leads to a pseudo-diploid locus with two non-functional
copies of the gene, one truncated at the 3′ end upstream and one truncated at the 5′ end downstream of the hDHFR cassette.
B. Southern blot analysis of DNA isolated from parasites transfected with pHH1Dggcs after two drug selection cycles (lane 2) in comparison
with non-transfected wild-type parasites (lane 1). No bands indicating integration at 1.2 kb and 5.2 kb are visible in lane 2, only the 2.6 kb
plasmid band and the 3.7 kb band corresponding to the endogenous ggcs locus.
C. Schematic representation of the endogenous gs locus, the pHH1Dgs plasmid and the recombined gs locus following integration of the
plasmid by single cross-over. Restriction sites for EcoRV and XhoI are indicated as well as the sizes of the expected DNA fragments. The
pHH1Dgs plasmid contains a insert homologous to gs but lacking the 5′ and 3′ ends (Dgs) and a hDHFR selectable marker cassette.
Integration of the plasmid causes the formation of a pseudo-diploid locus containing two non-functional copies of gs, the upstream copy being
truncated at the 3′ end and the downstream copy being truncated at the 5′ end.
D. Southern blot analysis of DNA isolated form parasite lines transfected with pHH1Dgs after two drug selection cycles (lane 2) in comparison
with wild-type parasites (lane 1). No integration speciﬁc bands at 7.8 kb and 1.3 kb are visible in the DNA from the transfected parasite line.
The endogenous gs speciﬁc band is visible in both wild-type and transfected parasites at 8.5 kb. In addition, a 1.3 kb band corresponding to
the plasmid is visible in the transfected parasites.
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parasites gene-speciﬁc and plasmid-speciﬁc bands were
still detected, suggesting that the parasites had devel-
oped resistance against 5-FC without loss of the episomal
plasmid (Fig. 2A and B; lane 3). Similar results were
obtained when analysing parasites transfected with
pCC4-gs. The Southern blot shows the bands diagnostic
for endogenous gs (0.9 kb and 4.8 kb) and the plasmid-
speciﬁc band of 5.9 kb in both untreated and 5-FC-treated
parasites after selection cycle 3 (Fig. 2C and D). These
data imply that both gene loci cannot be replaced by the
knockout constructs. This is again either due to refractory
Fig. 2. Gene replacement of ggcs and gs.
A. Schematic representation of the endogenous ggcs locus, the pCC4-ggcs knockout construct and the recombined ggcs locus following
integration. NdeI restriction sites for diagnostic Southern analyses and sizes of the expected DNA fragments are indicated. The positive
selectable marker blasticidin-S-deaminase (Bla) is ﬂanked by two regions homologous to the 5′ (Dggcs5′) and 3′ (Dggcs3′) end of ggcs and
replaces part of the target gene after recombination. The negative selectable marker cytosine deaminase (CD) is lost upon double cross-over
recombination.
B. Southern blot of parasites transfected with pCC4-ggcs in comparison with non-transfected wild-type parasites (lane 1). No integration was
observed after three drug selection cycles and the plasmid was still present (7.3 kb and 0.7 kb bands, lane 2). 5-FC resistant parasites were
obtained after drug selection cycle 3, but the plasmid was still present (lane 3).
C. Schematic diagram of the endogenous gs locus, the pCC4-gs knockout plasmid and the recombined gs locus following double cross-over
between the 5′ homologous fragment (Dgs5′) and 3′ fragment (Dgs3′) of pCC4-gs and the endogenous locus. EarI restriction sites used for
Southern analyses and diagnostic DNA fragment sizes are indicated.
D. Southern analyses of pCC4-gs transfected parasites. Lane 1 contains digested DNA from wild-type parasites. Lane 2 shows DNA isolated
from parasites in transfection cycle 3. In lane 3 DNA of 5-FC resistant parasites was loaded. The 0.9 kb and 4.8 kb bands diagnostic for the
endogenous gs locus are visible in all three lanes. The 5.9 kb plasmid band is present in transfected parasites (lanes 2 and 3). No bands
indicating plasmid integration into the gs gene locus are visible.
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parasite survival during development in the RBC even
when the medium has been supplemented with 1 mM
GSH.
Targeting of ggcs and gs loci is possible
In order to analyse whether the ggcs or gs loci were
refractory to recombination parasites were transfected
with pHH1-based knock-in constructs (Crabb et al.,
2004). The constructs lacked the ATG start codon but
contained the C-terminal part of either gene as outlined
in the Experimental procedures. Parasites were grown
without addition of exogenous GSH. In parasites trans-
fected with pHH1-ggcs the gene locus was targeted after
one selection cycle and parasites were cloned by limiting
dilution. Genotypes of the clones were veriﬁed by South-
ern blotting (Fig. 3A and B). The endogenous ggcs band
(3.7 kb) was no longer present while the two bands char-
acteristic for integration of the plasmid into the ggcs gene
locus (3.3 kb and 6.7 kb) were detected as shown for a
representative clone (Fig. 3B, lane 2). An additional band
represents the pHH1-ggcs plasmid still present in the
cloned parasite line.
Similarly the gs locus was targeted by the pHH1-gs
construct after two selection cycles and the cloned para-
sites were analysed by Southern blotting (Fig. 3C and D).
The diagnostic band for endogenous gs (6.4 kb) disap-
peared while those speciﬁc for the integration event into
the gs gene locus (1.8 kb and 7.9 kb) as well as the
plasmid pHH1-gs (3.3 kb) were detected in the represen-
tative clone (Fig. 3D).
Parasites were also co-transfected with the pCC4-ggcs
plasmid and an episomal expression plasmid
pCHD-ggcs(HA)3 to achieve the knockout of the ggcs gene
in the presence of an episomal copy of the gene. This
method has previously been used successfully for the
knockout of other essential genes (Krnajski et al., 2002;
Dorin-Semblat et al., 2008; Reininger et al., 2009).
However, this attempt was also unsuccessful because the
two transfected plasmids appeared to recombine after
transfection, which made a meaningful analysis of the
transfected parasite lines impossible (Fig. S1).
These data show that both gene loci are not refractory
to recombination and strongly suggest that they are not
targeted by the various knockout constructs because the
loss of ggcs or gs has negative effects on P. falciparum
growth during RBC development in vitro.
Uptake of GSH
One reason for the failure to generate P. falciparum ggcs
and gs null mutants may be that the parasites are depen-
dent on their endogenous GSH biosynthesis rather than
being able to take up sufficient exogenous GSH. Previous
studies investigating GSH uptake into P. falciparum are
conﬂicting, one suggesting that GSH cannot be taken up
into P. falciparum (Atamna and Ginsburg, 1997), while
another reports that the parasites are able to obtain GSH
from their environment albeit at low amounts (Raj et al.,
2009). Our data demonstrate that Plasmodium-infected
erythrocytes take up 1–1.5 pmol/1010 cells of [3H]-GSH in
20 min. This is only marginally higher than the amount of
[3H]-GSH that enters uninfected RBC and this difference is
not statistically signiﬁcant (Student’s unpaired t-test,
P > 0.05) (Fig. 4). In the presence of an excess of unla-
belled GSH the uptake of [3H]-GSH was similar to that
determined with [3H]-GSH only (Fig. 4). These data indi-
cate that GSH is not taken up by the parasitized RBC at
signiﬁcant rates and suggests that the rate of uptake is not
sufficiently high to compensate for the disruption of the
genes encoding gGCS and GS. Uptake of [3H]-GSH
into the parasite was also investigated in a longer-term
experiment where parasites were incubated with 24 nM
[3H]-GSH for 2 or 4 h respectively. The increase in
[3H]-GSH in the saponin-isolated parasites over this period
of time suggests that GSH can enter the parasites at low
rates (Fig. S2).
Elevated levels of gGCS in P. falciparum confer
resistance to BSO
We further probed whether GSH biosynthesis is important
for P. falciparum RBC development using the irreversible
suicide inhibitor of gGCS, BSO (Griffith, 1982). Previous
studies have not answered the question whether the lethal
effect of BSO is attributable to inhibition of host cell gGCS
or the parasite enzyme (Lüersen et al., 2000). Therefore a
P. falciparum line was generated that expressed gGCS
C-terminally (HA)3-tagged from an episome (Fig. 5). The
mutant parasite line was named D10gGCS. Presence of the
episome and expression of the (HA)3-tagged protein were
veriﬁed by Southern and Western blotting (Fig. 5Aand B).
The Southern blot of the transfected parasites shows the
presenceoftheendogenousgene(3.7 kb)andtheplasmid
pCHD-ggcs(HA)3 (9.9 kb) (Fig. 5A) and the Western blot
shows expression of the (HA)3-tagged protein in D10gGCS
(130 kDa; Fig. 5B). In agreement with an overexpression
of gGCS, the enzymatic activity in the transgenic parasite
line was increased from 2.9  1.1 nmol min-1 mg-1 of
protein in the D10 parent line to 5.0  1.2 nmol min-1 mg-1
of protein in D10gGCS. If growth inhibition is caused by the
inhibition of the parasite gGCS, elevated levels of the
parasite enzyme should result in increased tolerance to
BSO. Indeed, the IC50 value for BSO was signiﬁcantly
increased from 58.0  1.3 mM for wild-type D10 para-
sites to 111.3  11.1 mM for D10gGCS mutant parasites
(P < 0.001, Student’s unpaired t-test) (Fig. 5C), which is in
good agreement with the increased level of gGCS activity.
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type and D10gGCS were found (Fig. 5D, white bars). More-
over, incubation of both parasite lines with 50 mM BSO
for 2 h resulted in a similar reduction of GSH level (D10
from 832  50 to 138  41 nmol/1010 cells and D10gGCS
757  85 to 199  74 nmol/1010 cells; Fig. 5D, black
bars; P < 0.001, One-way ANOVA with Newman–Keuls
post test).
Elevated levels of gGCS lead to a decrease in GR
abundance and enhanced efflux of the peptide
One potential reason as to why GSH levels are not
elevated in D10gGCS and why BSO does not have a differ-
ential effect on parasite GSH levels during a short-term
incubation, may be differences in the regulation of GSH
metabolism. Other enzymes inﬂuencing GSH levels, apart
Fig. 3. Targeting of ggcs and gs loci is possible.
A. Schematic diagram of the endogenous ggcs locus, the pHH1-ggcs plasmid and the recombined ggcs locus following single cross-over
recombination between the plasmid and the 3′ region of ggcs. The plasmid contains a human dihydrofolate reductase selectable marker
(hDHFR) cassette, a region homologous to the 3′ end of ggcs (ggcs-con) allowing for recombination with the target gene and an artiﬁcial 3′
UTR (P. berghei dihydrofolate reductase/thymidylate synthase 3′ UTR, PbDT-3′). NdeI restriction sites and sizes of the resulting diagnostic
DNA fragments are indicated.
B. Southern blot of wild-type parasites (lane 1) in comparison with a representative clone (lane 2) in which the ggcs locus has been targeted
by the pHH1-ggcs control plasmid. The 3.7 kb endogenous ggcs band was only visible in the wild type (lane 1). In the cloned parasites (lane
2) two bands (3.3 kb and 6.7 kb) diagnostic for integration of the plasmid into the ggcs gene locus were detected. The pHH1-ggcs plasmid
(6.4 kb) was still present in the cloned parasite line.
C. Schematic diagram of the gs locus, the pHH1-gs plasmid and the recombined gs locus following integration. The plasmid contains an
hDHFR selectable marker cassette and a homologous fragment to the 3′ end of gs (gs-con) with an artiﬁcial downstream 3′ UTR (PbDT-3′).
EcoRI and XhoI restriction sites used for diagnostic digest and Southern blotting are indicated as well as the sizes of the resulting DNA
fragments.
D. Southern blot analysis of wild-type parasites (lane 1) in comparison with a representative cloned parasite line (lane 2) bearing the
recombined gs locus following integration of pHH1-gs. The 6.4 kb band corresponding to endogenous gs was only detectable in the DNA
isolated from wild-type parasites. In the cloned parasite line two bands speciﬁc for integration in the gs gene locus of 1.8 kb and 7.9 kb were
visible (lane 2). The plasmid (3.3 kb) was still detectable in the cloned parasite line.
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The protein levels of both enzymes were determined by
Western blotting (Fig. 6A and B) and subsequent densito-
metricanalyses(Fig. 6C).WhilethelevelsofGSTwerenot
signiﬁcantlyalteredinD10gGCScomparedwithD10(Fig. 6A
and C), the amount of GR was signiﬁcantly reduced by
50% in D10gGCS (Fig. 6B and C; Student’s unpaired t-test;
P < 0.001). A decrease in GR protein is likely to diminish
the ability of the parasites to reduce GSSG to GSH and
may result in an enhanced efflux of GSSG to maintain the
intracellular redox balance. To test this hypothesis we
determined the amount of total GSH that the parasites
excreted into the culture medium over a 90 min period
(Fig. 6D). Indeed the efflux rate increased from 1239 
74 nmol h-1/1010 cells to 1844  123 nmol h-1/1010 in
D10gGCS (Student’s unpaired t-test, P = 0.01) compared
with that determined in D10. Together these data explain
why D10gGCS do not contain higher levels of GSH despite
displaying elevated gGCS activity because they concomi-
tantlyloosemoreofthepeptideattributabletoanincreased
efflux in comparison with wild-type parasites.
Discussion
Glutathione, a vital low molecular weight thiol in most
organisms, is synthesized in two consecutive steps cataly-
sedbygGCSandGSinP. falciparum(Lüersenet al.,1999;
Meierjohann et al., 2002a), similar to other organisms. In
this study we have attempted to generate mutant P. falci-
parum lacking the ability to synthesize GSH de novo. GSH
biosynthesis is not essential in a variety of organisms such
as Escherichia coli (Bouter et al., 1988; Lee et al., 2001),
Saccharomyces cerevesiae (Lee et al., 2001), Candida
albicans (Baek et al., 2004) and T. brucei (Huynh et al.,
2003), as long as the tripeptide is provided in sufficiently
high concentration in the extracellular environment. Inter-
estingly, S. cerevesiae mutants lacking gs are viable even
whentheyarenotsupplementedwithGSHandcansurvive
by using the GSH precursor g-glutamylcysteine (gGC) as a
substitute (Grant et al., 1997). Generally, organisms
lacking a functional GSH biosynthetic pathway exhibit
increased susceptibility towards abiotic stress and eukary-
otic cells are particularly prone to damage of their mito-
chondria (Martensson and Meister, 1989; Grant et al.,
1996; Lee et al., 2001; Lash, 2006).
Recently, it was reported that the intra-erythrocytic
stages of the rodent malaria species P. berghei are also
able to grow and differentiate into gametocytes without a
functional GSH biosynthesis pathway (Vega-Rodriguez
et al., 2009) and it is likely that these ggcs null mutants
obtain GSH from their host as low levels of the peptide are
still detectable in the knockout lines. However, sexual
development of P. berghei is stopped in the insect where
mitochondrial integrity is compromised due to the loss of
gGCS function (Vega-Rodriguez et al., 2009).
In contrast to these ﬁndings, this study suggests that
GSH biosynthesis is crucial not only for the development
of the parasites in the insect vector but that it also has a
vital function for intra-erythrocytic growth of the human
malaria parasite P. falciparum. A loss of gGCS or GS
function was not compensated by elevated levels of GSH
in the culture medium; even 1 mM GSH, which is well
above the concentration found in mammalian plasma and
serum (Wendel and Cikryt, 1980; Jeevanandam et al.,
2000; Scibior et al., 2008) does not facilitate the disruption
or deletion of the genes involved in the biosynthesis of
GSH. This is not due to refractory gene loci as the ggcs
and gs loci were both targeted with control knock-in con-
structs, supporting our hypothesis that GSH biosynthesis
has a vital function for P. falciparum. One reason for this
absolute requirement in P. falciparum may be their inabil-
ity to obtain sufficiently high amounts of GSH from their
environment to compensate for the loss of GSH biosyn-
thesis function. This is corroborated by a recent study by
Raj and colleagues that showed a rate of GSH uptake of
12 pmol h-1/1010 (Raj et al., 2009), which, although higher
than the uptake determined in this study, still is not suffi-
ciently high to compensate for the substantial loss of GSH
from the parasites during in vitro growth. It was deter-
mined that the parasitized RBC excrete 1239  74 nmol
Fig. 4. Uptake of [
3H]-GSH. Uptake of [
3H]-GSH was compared in
uninfected () and puriﬁed trophozoite-infected RBC (). Cells
were incubated with 24 nM [
3H]-GSH and at indicated time points
aliquots were withdrawn and the cell-associated label was
determined. The amount of [
3H]-GSH associated with either
uninfected RBC or infected RBC did not signiﬁcantly increase over
20 min (P > 0.05, unpaired Student t-test). The amount of [
3H]-GSH
taken up by MACS puriﬁed infected RBC after 20 min was not
signiﬁcantly higher than in the control RBC treated in the same way
(P > 0.05, unpaired Student’s t-test). An excess of unlabelled GSH
(3 mM) did not signiﬁcantly inhibit the amount of [
3H]-GSH
associated with puriﬁed trophozoite infected RBC () but lowered
the amount of [
3H]-GSH associated with uninfected RBC (D) over
20 min. Data represent means of four independent
determinations  SEM.
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studies corroborating our observation (Atamna and Gins-
burg, 1997; Ayi et al., 1998; Lüersen et al., 2000). These
results emphasize the necessity for P. falciparum to con-
stantly generate GSH de novo in order to maintain
adequate levels of the tripeptide. In fact the rate of GSH
biosynthesis is higher than the rate of GSSG efflux from
infected RBC (gGCS activity was determined to be
80–140 nmol min-1/1010 cells) (Lüersen et al., 2000;
Meierjohann et al., 2002b) guaranteeing an adequate
Fig. 5. Episomal expression of gGCS-(HA)3 leads to increased BSO resistance.
A. Southern blot analysis of wild-type D10 parasites (lane 1) in comparison with D10
gGCS transfected with expression plasmid pCHD-ggcs(HA)3
(lane 2). The 3.9 kb band corresponding to endogenous ggcs and the 9.9 kb band diagnostic for the plasmid are indicated.
B. Western blot analysis with anti-(HA)3 antibody (mouse, 1:1000) conﬁrmed expression of gGCS-(HA)3 in D10
gGCS. As a loading control an
anti-P. falciparum 1-Cys peroxiredoxin antibody (a-TSAI, rabbit 1:120 000) was used.
C. The BSO IC50 for wild-type D10 () was signiﬁcantly lower (58.0  2.2 mM) than for D10
gGCS (, 111.2  11.1 mM) parasites expressing
gGCS-(HA)3 (P < 0.001, unpaired Student’s t-test). Data represent means of three independent determinations, each done in duplicate. Error
bars represent SD.
D. GSH levels in D10 and D10
gGCS under normal growth conditions and after incubation with 50 mM BSO for 2 h. Results represent
means  SEM of 3 to 5 independent determinations. There were no signiﬁcant differences of GSH levels found between D10
(832  50 nmol/10
10 cells) and D10
gGCS parasites (757  85 nmol/10
10 cells) grown in normal culture medium. Exposure to BSO signiﬁcantly
decreased GSH levels in both D10 and D10
gGCS to 138  41 and 199  74 nmol/10
10 cells respectively. Statistical analyses were performed
using one-way ANOVA and Newman–Keuls post test (***P < 0.001).
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reason as to why the parasitized RBC excrete GSH at
such a high rate may be the requirement and relative
cost of the GR cofactor NADPH needed to maintain GSH
in its reduced form. However, this remains subject to
further investigations, which are beyond the scope of this
study.
Furthermore, P. berghei preferentially infects reticulo-
cytes, (Janse et al., 1989) which suggests that different
host cell preference may inﬂuence the ability of these
parasitestosurvivewithoutafunctionalGSHbiosynthesis.
Unlike mature erythrocytes, reticulocytes likely still have a
functional g-glutamyltranspeptidase, which would supply
the infected cell with the ability to take up GSH from host
plasma. This ability may give P. berghei a safety net that
provides them with adequate amounts of GSH from their
host during intra-erythrocytic development, which is lost in
the mature erythrocytes that P. falciparum preferably
infects (Meister et al., 1981). However, the GSH concen-
tration in mature erythrocytes is in the mM range (Griffith,
1981), and it is surprising that P. falciparum appear not to
use this rich source of the tripeptide. Even if GSH is taken
up from the host cell into the digestive vacuole through
phagocytosis it is likely digested into its amino acid com-
ponents.Thesethenindividuallyentertheparasitecytosol,
but in the absence of a functional GSH biosynthesis the
parasites cannot utilize the amino acids to rebuild the
tripeptide.
This study also provides evidence that in contrast to S.
cerevisiae, P. falciparum is unable to exploit gGC as a
substitute for GSH because it was also impossible to
delete P. falciparum gs. Even though gGC itself has reduc-
ing properties, GSH-dependent enzymes such as GSTs,
glutaredoxins and glyoxalases in P. falciparum are likely
to be unable to make use of the dipeptide as a reducing
cofactor. Another problem may be that gGC-disulphide is
not efficiently reduced by GR, which would result in an
imbalance of the intracellular redox homeostasis.
Fig. 6. Regulation of GSH levels by GR activity and GSSG efflux.
A. Western blot for GST expression using anti-P. falciparum GST antibody (a-GST, rabbit, 1:5000) and anti-P. falciparum 1-Cys peroxiredoxin
antibody (a-TSAI, rabbit, 1:120 000) as loading control.
B. GR expression level using anti-GR antibody (a-GR, rabbit, 1:30 000) and anti- P. falciparum 1-Cys peroxiredoxin (a-TSAI, rabbit, 1:120 000)
as loading control.
C. Relative expression of GST and GR in D10
gGCS normalized to expression in wild-type D10 parasites. Results are means of 3 to 4
independent determinations  SEM (*P < 0.05, unpaired Student’s t-test).
D. Efflux of total GSH/GSSG from D10 () and D10
gGCS (). The efflux rate was signiﬁcantly higher in D10
gGCS (1844  123 nmol h
-1/10
10
cells) than in wild-type D10 (1239  74 nmol h
-1/10
10 cells) (unpaired Student’s t-test, P = 0.01).
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gated using the irreversible inhibitor of the enzyme BSO
(Griffith, 1982). Overexpression of gGCS in the parasites
resulted in an increased IC50 value for BSO, implying
that the inhibition of the parasite enzyme is the cause for
the observed anti-plasmodial effect. Presumably the
suicide inhibitor is sequestered by elevated levels of the
target protein in D10gGCS, indicated by the increased
gGCS activity determined in mutant parasites. However,
the GSH levels remained unchanged in D10gGCS, which
is attributable to the reduction of GR and the increased
efflux of the tripeptide.
When the parasites were incubated for 2 h with BSO
(rather than 72 h as in the IC50 experiment), mutant
and wild-type parasites displayed a similar loss of GSH.
One might expect a less pronounced loss of GSH
from D10gGCS in comparison with wild-type, because
of elevated levels of gGCS. However, as efflux is
increased, BSO inhibition of gGCS is likely to reduce
GSH biosynthesis rate below the efflux rate, resulting in
a similar decrease of GSH in both parasite lines. The
increased IC50 value for BSO of D10gGCS seems to con-
tradict this interpretation. However, over a longer term of
incubation with BSO it is well possible that D10gGCS para-
sites reduce their loss of GSH possibly by upregulating
GR activity or downregulating efflux of the tripeptide.
Alternatively, containing multiple copies of the g-gcs
gene under the control of a strong promoter may allow
gGCS activity to recover faster because of higher levels
of re-expression of the protein.
Overall our data demonstrate that the parasites regu-
late their intracellular GSH levels tightly to guarantee an
adequate GSH/GSSG redox homeostasis. Major regula-
tory processes include GSSG reduction, GSSG efflux
and GSH biosynthesis, which is in agreement with
reverse genetic studies in P. berghei that have also indi-
cated a role for GR in regulating GSH levels (Buchholz
et al., 2010; Pastrana-Mena et al., 2010).
There is mounting evidence for substantial differences
between the requirements of human and rodent Plasmo-
dium species regarding their antioxidant defences.
Reports in P. berghei show that in the rodent parasite
ggcs, gr and thioredoxin reductase are dispensable
during erythrocytic development (Vega-Rodriguez et al.,
2009; Buchholz et al., 2010; Pastrana-Mena et al.,
2010), while studies in P. falciparum suggest that thiore-
doxin reductase (Krnajski et al., 2002) and glutathione
biosynthesis (this work) are essential for parasite
survival during RBC development. Our data support
the hypothesis that the level of redundancy between
the antioxidant and redox systems operating in the
two Plasmodium species may differ fundamentally, a




Ancotil (5-ﬂuorocytosine, 5-FC) was obtained from The Royal
Inﬁrmary Pharmacy, Glasgow, UK. WR99210 was a kind gift
from Jacobs Pharmaceuticals (USA). Plasmids pHH1, pCC4,
PfHsp865’-pDONR4/1, 3xHAc-pENTR2/3 and pCHD-3/4
were kind gifts of Professor A. F. Cowman (The Walter and
Eliza Hall Institute, Melbourne, Australia) and Professor G. I.
McFadden (University of Melbourne, Melbourne, Australia)
(Crabb, 2002; Crabb et al., 2004; van Dooren et al., 2005;
Braks et al., 2006; Maier et al., 2006). Blasticidin was pur-
chased from Invitrogen. Antibodies used in Western blot
experiments were obtained from Promega and Eurogentec.
Anti-GST antibodies were a kind gift from Professor E. Liebau
(University of Münster, Germany). All chemicals were pur-
chased from Sigma UK unless otherwise stated.
Plasmodium culture
Plasmodium falciparum 3D7 (The Netherlands) and D10
(Papua New Guinea) were used in this study. The parasites
were cultured according to (Trager and Jensen, 1976) in
RPMI 1640 supplemented with 0.5 % (w/v) Albumax II,
200 mM hypoxanthine, 20 mgm l
-1 gentamycin (complete
RPMI 1640 medium) in human erythrocytes at a haematocrit
between 2.5% and 5%. Parasite cultures were maintained
under low oxygen pressure (1% oxygen, 5% CO2 and 94%
N2) at 37°C. Assays to determine IC50 values for BSO were
performed according to Desjardins et al. (1979) using com-
plete RPMI 1640 medium without hypoxanthine and supple-




-1, American Radiolabelled Chemicals, USA).
Protein for Western blotting was isolated from parasites
obtained after saponin lysis (Umlas and Fallon, 1971). Para-
site pellets were resuspended in lysis buffer (100 mM
HEPES, pH 7.4 containing 5 mM MgCl2, 10 mM EDTA, 0.5%
Triton X-100, 5 mg RNase A, 1 mM phenylmethanesulfonyl
ﬂuoride (PMSF), 1 mM benzamidine, 2 mgm l
-1 leupeptin.
10 mM E-64, 2 mM 1,10 phenanthroline, 4 mM pepstatin) and
lysed by three cycles of freeze/thawing followed by 5 min
centrifugation at 17 000 g. Concentration of soluble protein
was determined using the Bradford assay with bovine serum
albumin as a standard (Bradford, 1976). Genomic DNA was
isolated from saponin isolated parasites (Umlas and Fallon,
1971) using the QiaAMP DNAmini kit according to the manu-
facturers recommendations (Qiagen, UK).
Generation of transfection constructs
For the disruption of ggcs and gs genes the plasmid pHH1
(Crabb et al., 2004) was used. This plasmid contains a
human dehydrofolate reductase (hDHFR) cassette for posi-
tive selection of transfected parasites. Fragments homolo-
gous to either ggcs or gs were cloned into the plasmid using
BglII and XhoI restriction sites. These fragments were trun-
cated at the 5′ end and lacked theATG start codon as well as
being truncated at the 3′ end and containing an artiﬁcial stop
codon. Single cross-over recombination between the plas-
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functional copies, one lacking the 5′ end and start codon and
one lacking the 3′ end and containing a premature stop
codon. The 800 bp insert for ggcs (bp 181–981 of ggcs ORF)
was ampliﬁed using the primers GCS-1 and GCS-2 (Table 1)
and the 1004 bp insert for gs (bp 121–1125 of gs ORF) was
ampliﬁed using the primer pair GS-1/GS-2.
For knockout of ggcs and gs by double cross-over recom-
bination the plasmid pCC4 was used (Braks et al., 2006;
Maier et al., 2006). The constructs in pCC4 contained one
region homologous to the 5′ end of the respective target gene
in the multiple cloning site upstream of the selectable marker
cassette and a second insert homologous to the 3′ region of
the respective gene downstream of the selectable marker
cassette. The 485 bp 5′ fragment of ggcs (bp 18–502 of ggcs
ORF) was ampliﬁed with primer pair GCS-3/GCS-4 (Table 1),
which contained SacII and AﬂII restriction sites respectively.
The 522 bp 3′ fragment of the gene (bp 2549–3070 of ggcs
ORF) was ampliﬁed using GCS-5/GCS-6 (Table 1) containing
an NcoI and NarI restriction site respectively. Similarly,
pCC4-gs was generated using primer pair GS-3/GS-4 to
amplify a 480 bp 5′ region of the gene (bp 65–542 of gs ORF)
and GS-5/GS-6 to amplify a 480 bp 3′ region of the gene (bp
1468–1942 of gs ORF). The fragments were restricted and
subcloned into pCC4 previously cut with the respective
enzymes.
Knock-in control constructs were generated by cloning a
homologous region corresponding to the 3′ ends of ggcs and
gs into the plasmid pHH1 (Crabb et al., 2004). The 1323 and
1007 bp fragments of ggcs and gs were ampliﬁed using
the primers GCS-7/GCS-8 and GS-7/GS-8, respectively
(Table 1). The primers introduced a BglII and an XhoI site at
the 5′ and 3′ ends of the PCR products, respectively, and
allowed directional cloning into the pHH1 plasmid. Single
cross-over recombination of the knock-in plasmid with the
respective gene locus results in a functional copy of ggcs and
gs and a non-functional pseudogene downstream of the func-
tional copy. Recombination with the target gene will however
introduce an artiﬁcial 3′ UTR (P. berghei dihydrofolate
reductase/thymidylate synthase 3′ UTR) downstream of the
functional gene copy.
To express ggcs from an extrachromosomal copy to elevate
intracellular gGCS levels, the full-length gene was ampliﬁed
using GCS-9/GCS-10 (Table 1) and the PCR product was
subcloned into the pENTR/D-TOPO vector (Invitrogen).
To introduce a promoter to the expression cassette, the
PfHsp86-5′-pENTR/1 entry clone was used (van Dooren
et al., 2005) and the gene was C-terminally tagged with an
(HA)3-tag using 3xHAc-pENTR2/3 in the LR clonase reaction
(Invitrogen). The destination plasmid used was pCHD-3/4
(van Dooren et al., 2005).
All plasmid sequences were veriﬁed by nucleotide
sequencing (The Sequencing service, University of Dundee).
Transfection and selection of parasites
Before transfection parasite cultures were synchronized
according to Lambros and Vanderberg (1979). Ring stage
infected erythrocytes at a parasitaemia of 4–7% were
washed in cytomix (120 mM KCl, 0.15 mM CaCl2,2 m M
EGTA, 5 mM MgCl2,1 0m MK 2HPO4/KH2PO4 pH 7.6, 25 mM
HEPES pH 7.6) (Crabb and Cowman, 1996; Crabb et al.,
2004) and 200 ml of erythrocytes was mixed with 70–100 mg
of plasmid DNA resuspended in 400 ml cytomix. The cells
were electroporated at 310 V and 950 mF using a Gene
Pulser Xcell electroporator (Bio-Rad). Transfected parasites
were then placed into 10 ml pre-warmed complete RPMI
1640 medium and the haematocrit adjusted to 5%. Six to 8 h
after transfection the culture medium was changed and the
appropriate selection drug was added to the cultures. Trans-
fectants were visible in Giemsa stained thin smears 4–6
weeks after transfection. Transfected parasites were cloned
by limiting dilution according to Kirkman et al. following inte-
gration of the plasmids (Kirkman et al., 1996).
Southern blotting
To analyse the genotypes of the transfected parasite lines
diagnostic Southern blotting was performed. One mgo f
genomic DNA was subjected to digestion using diagnostic
restriction enzymes over night at 37°C and the digested DNA
was subsequently separated on a 0.8% agarose gel before
blotting onto nitrocellulose using a VacuGene XL blotting
apparatus (GE HealthCare). Probes corresponded to the
inserts of the respective plasmids used for transfection and
were labelled with thermostable alkaline phosphatase using
the Gene images AlkPhos Direct Labeling and Detection kit
(GE HealthCare, UK) following manufacturer’s instructions.
Blots were probed over night at 55°C according to manufac-
turer’s instructions before washing and the hybridization pat-
terns were determined by exposure to autoradiography ﬁlms
(Kodak) from 1 to 16 h.
Western blotting
T e nt o2 0mg of parasite protein extracts were separated by
SDS-PAGE under reducing conditions before proteins were
Table 1. Primers used in this study.
Primer Sequence
GCS-1 GCGC AGATCT CGTTATGATGAAAATATAATGTTTGG
GCS-2 GCGC CTCGAG ATCTTGTGTATTTGAACTATCATTAAC
GCS-3 GCGC AGATCT GATGTAATACTTGACAAAAATG
GCS-4 GCGC CTCGAG TTATGCACTCAGTTCGTAC
GCS-5 GCGC CCGCGG CGGAACGCCATTAAGCTGGGATG
GCS-6 GCGC CTTAAG CATGGCCAGTAATTCTTCTAGCC
GCS-7 GCGC CCATGG GAGCATCCAAAAGAGAAGCTTTAAC
GCS-8 GCGC GGCGCC GCAAGTATTGCGTATAATCCTCTCC
GCS-9 CACC ATGGGTTTTCTAAAAATCGGAACG
GCS-10 TGCACTCAGTTCGTACATTTTTTTTGC
GS-1 GCGC AGATCT GATATGATTGCTTTTTTGAATAC
GS-2 GCGC CTCGAG GTCGTTCAAATCGATAAGAAG
GS-3 GCGC AGATCT CATGAAGATGATTTTAATAGTTTTG
GS-4 GCGC CTCGAG CTCAATGTTCAGTTAAAAAAAAAG
GS-5 GCGC CCGCGG GTCCCAATGGAAAGAATGAATATC
GS-6 GCGC CTTAAG CGATTAGTCATATAATCAGATCTTCC
GS-7 GCGC CCATGG GCCTTACAAGTAGACCCATCTC
GS-8 GCGC GGCGCC CCAAGCTTGATATACCACAAATGG
Restriction sites within the primer sequences used for directional
cloning are indicated in italics.
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system (Bio-Rad) according to manufacturer’s instructions.
The primary mouse anti-HA, rabbit anti-GR antibodies and
rabbit anti-1-Cys peroxiredoxin antibodies (all Eurogentec)
were used at 1:1000, 1:30 000 and 1:120 000 dilutions,
respectively. The rabbit anti-GST antibodies were used at
1:5000 dilution. The secondary anti-mouse-HRP conjugate or
anti-rabbit-HRPconjugate(Promega)antibodieswereusedat
1:10 000 dilutions. The protein bands reacting with the anti-
bodies were detected using the Millipore Immobilon Western
Blot detection kit and visualized by exposing blots to autorad-
iography ﬁlms (Kodak).
Puriﬁcation of trophozoite-infected RBC using magnet
activated cell sorting (MACS) columns
Trophozoite-infected RBC were resuspended in 10 ml Earle’s
balanced salt solution (EBSS; Thermo HyClone) and applied
to a CS MACS column placed into the magnetic ﬁeld of a
VarioMACSseparator(MiltenyiBiotech).Trophozoite-infected
RBC were retained while uninfected RBC were washed
through the column with 50 ml EBSS. The infected RBC were
eluted by removing the column from the magnetic ﬁeld and
washing it with 30 ml EBSS using a syringe. The puriﬁed
trophozoite-infected RBC were centrifuged for 5 min at 700 g,
4°C and the supernatant was removed. The puriﬁed cells had
a parasitaemia of 85–90% and were carefully resuspended
in EBSS at a cell number appropriate for the following
applications.
GSH uptake assays
MACS-puriﬁed infected RBC were resuspended in pre-
warmed EBSS at 2 ¥ 10
8 cells ml
-1. As a control non-infected
RBC were used at the same cell count. An equal volume of
EBSS containing only 48 nM [
3H]-GSH (2 mCi ml
-1, American
Radiolabelled Chemicals, USA) or 48 nM [
3H]-GSH and
6 mM cold GSH was added and carefully mixed, giving ﬁnal
concentrations of 24 nM [
3H]-GSH and 3 mM cold GSH. The
cells were incubated in a water bath at 37°C and at various
time points 200 ml samples corresponding to 2 ¥ 10
7 RBC
were removed and cells were immediately separated from
the uptake solution by centrifugation through 300 ml dibu-
tylphthalate as described in Biagini et al. (2005) and Quashie
et al. (2008). The uptake solution was removed and the tube
walls carefully rinsed with H2O and wiped with a clean tissue.
The oil was removed and cells were lysed in 100 mlH 2O. To
bleach haemoglobin 50 mlH 2O2 were added followed by the
addition of 50 ml acetic acid. Three millilitres of scintillation
cocktail were added and the samples were counted the fol-
lowing day in a Wallac Trilux MicroBeta scintillation counter.
GSH efflux
MACS-puriﬁed trophozoite-infected RBC were resuspended
in 350 ml EBSS and the cell number was determined using a
haemocytometer. GSSG-efflux was analysed by incubating
puriﬁed infected RBC at 37°C in EBSS removing 50 mlo ft h e
cell suspension at various time points. The cells were pelleted
by centrifugation at 400 g for 2 min in a benchtop centrifuge
and 25 ml of the supernatant was used for derivatization of
thiols as described below.
Determination of gGCS activity
gGCS activity was determined as previously described
(Lüersen et al., 2000) with minor modiﬁcations. The 100 ml
reaction contained 0.1 M Tris-HCl buffer, pH 8.0, 20 mM
MgCl2, 2 mM EDTA, 10 mM L-a-aminobutyrate, 10 mM ATP,
5 mM creatine phosphate, 1 unit of creatine phosphokinase,
10 mM [U-
14C] glutamate (1 mCi, 270 mCi mmol
-1) and 30 mg
ofparasitelysateobtainedfromwildtypeandmutantparasites
after saponin lysis. The reaction was incubated for 45 min at
37°C before the reaction was stopped by addition of 10 mlo f
2 M HClO4 and heating to 95°C for 3 min. After centrifugation
at 13 000 g for 5 min, 10 ml of the supernatant was applied to
thin layer chromatography plates (cellulose F plastic sheets,
20 ¥ 20 cm; 0.1 mm thickness; Merck). The reaction products
were separated using butan-1-ol/acetic acid/water (12:3:5,
by volume) for 24 h. The plates were dried and exposed to
ﬁlm for at least 24 h to visualize the reaction product
g-glutamylaminobutyrate as a spot on the ﬁlm.The radioactive
spots were cut out, transferred into 3 ml scintillation ﬂuid and
the radioactivity determined in a WallacTrilux MicroBeta liquid
scintillation counter. The speciﬁc activity was calculated
according to amount of parasite protein and is given in




Determination of GSH level
Parasites were isolated from 20 ml of synchronized culture
(~ 2–5 ¥ 10
7 parasites) by saponin lysis and GSH levels were
determined by HPLC as described by Williams et al. (Will-
iams et al., 2009). The cells were washed once with EBSS
before lysis of RBC with 0.15% saponin (for 5 min on ice),
followed by three washes with EBSS at 4°C. The parasite
number was determined using a haemocytometer and the
parasites were incubated for 45 min at room temperature in
50 ml of derivatization buffer (40 mM N-[2-hydroxyethyl]-
piperazine-N′[3-propanesulfonic acid], 4 mM diethylenetri-
amine pentaacetic acid, pH 8.0), containing 0.7 mM tris(2-
carboxyethyl)phosphine to allow reduction of thiols. 50 mlo f
2 mM monobromobimane in ethanol were added and
samples heated to 70°C for 3 min. After a brief cooling period
extracts were deproteinized for 30 min on ice by addition of
100 ml 4 M methanesulfonic acid, pH 1.6. Precipitated protein
was removed by centrifugation in an Eppendorf benchtop
centrifuge for 40 min at 16 000 g at 4°C. The supernatant
was analysed by HPLC as described by Williams et al.
(Williams et al., 2009).
Statistical analyses
For statistical analyses GraphPadPrism software was used.
Results are represented as means  standard deviation
(SD) or standard error of the mean (SEM). Data were analy-
sed by unpaired Student’s t-test for two groups or by one-way
ANOVA and Newman–Keuls post test for multiple groups.
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